HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
No edit summary |
||
| Line 139: | Line 139: | ||
|[[HAEM5:Systemic mastocytosis|Systemic mastocytosis]]||Disease||PENDING|| || || || ||FQR|| || | |[[HAEM5:Systemic mastocytosis|Systemic mastocytosis]]||Disease||PENDING|| || || || ||FQR|| || | ||
|Systemic Mastocytosis | |Systemic Mastocytosis | ||
| | |Abdullah Osme, MD, University Hospitals Cleveland Medical Center, Case Western Reserve University Shashi Shetty, Ph.D. FACMG, FCCMG, University Hospitals Cleveland Medical Center, Case Western Reserve University | ||
|Complete | |Complete | ||
| | | | ||
| Line 1,716: | Line 1,716: | ||
| | | | ||
|Mantle Cell Lymphoma | |Mantle Cell Lymphoma | ||
| | |Mahsa Khanlari, MD and Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas | ||
|Pending | |Pending | ||
| | | | ||